0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Effect of Local Physical Training on the Forearm Arteries and Veins in Patients with End-Stage Renal Disease

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Aim: We investigate the effects of local training on the forearm vessels in patients with end-stage renal disease. Methods: Fourteen hemodialysis patients were included. Handgrip training was performed for 8 weeks. The following parameters were measured at the beginning of the study and 4 and 8 weeks later: forearm circumference, maximal handgrip strength, and artery and vein parameters, including endothelium-dependent and endothelium-independent vasodilatation (using ultrasound and duplex Doppler scanning). Results: The maximal handgrip strength increased significantly. The radial artery diameters were significantly higher after 8 weeks of training. The endothelium-dependent vasodilatation was found to be significantly increased after 4 and 8 weeks of training. The maximal vein diameters increased significantly with training, with preserved distensibility. Conclusions: The present study suggests that regular handgrip training increases the diameters of forearm vessels. It also improves endothelium-dependent vasodilatation. These changes point to the possible beneficial effects of daily handgrip training in chronic renal failure patients before arteriovenous fistula construction.

          Related collections

          Most cited references 2

          • Record: found
          • Abstract: found
          • Article: not found

          Native arteriovenous fistula: preoperative evaluation.

           Marko Malovrh (2002)
          Duplex sonography recently has been recognized as an objective and noninvasive method to assess morphological and functional parameters of vessels that could predict arteriovenous fistula (AVF) patency and time of adequate maturation. To prospectively study prognostic indicators of native AVFs, forearm arteries and veins of patients with end-stage renal disease were examined by duplex sonography before AVF construction. Several anatomic parameters, including feeding artery internal diameter (IDA), resistance index (RI), and arterial blood flow (Q(A)) before and at reactive hyperemia (RH) and internal diameter of the vein (IDV) before and after proximal vein compression (PVC), were measured. Measurements of the feeding artery were repeated at different periods after native AVF construction. One hundred sixteen patients were included on the study. The primary patency rate (successful constructed AVF) of native AVFs was 80.2%. In this group, mean values for IDA were 0.264 cm; RI at RH, 0.50; and Q(A), 54.5 mL/min. IDV increased after PVC for 59.3%. In the group with failed AVFs (19.8%), mean IDA was 0.162 cm; RI at RH, 0.70; and Q(A), 24.1 mL/min. IDV increased after PVC for only 12.4%. Patency rates after surgery in a group with IDAs greater than 0.16 cm was 93%, and with IDAs of 0.16 cm or less, 32%. In a group with RIs at RH less than 0.7, the patency rate was 95.3%, and with RIs of 0.7 or greater, 38.7%. An AVF feeding artery Q(A) of 300 mL/min was achieved in the group with IDAs greater than 0.16 cm, those with RIs at RH less than 0.7 after 1 week, those with IDAs of 0.16 cm or less between 3 and 8 weeks, and those with RIs of 0.7 or greater between 8 and 12 weeks. This study shows that duplex sonography may provide useful data on preoperative morphological and functional characteristics of vessels used for AVF construction. Increase in IDA, Q(A), RI at RH, and IDV after PVC are important to predict AVF primary patency rate. Based on these measurements, the most adequate location for AVF construction, as well as time of optimal AVF development, can be determined, particularly for patients at greater risk for primary failure, such as the elderly and patients with diabetes. Copyright 2002 by the National Kidney Foundation, Inc.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Effect of hyperhomocysteinemia on endothelial activation and dysfunction in patients with end-stage renal disease.

              Bookmark

              Author and article information

              Journal
              BPU
              Blood Purif
              10.1159/issn.0253-5068
              Blood Purification
              S. Karger AG
              0253-5068
              1421-9735
              2003
              2003
              03 November 2003
              : 21
              : 6
              : 389-394
              Affiliations
              Departments of aPediatric Nephrology and bNephrology, University Medical Centre, Ljubljana, Slovenia
              Article
              73441 Blood Purif 2003;21:389–394
              10.1159/000073441
              14586181
              © 2003 S. Karger AG, Basel

              Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

              Page count
              Tables: 2, References: 26, Pages: 6
              Product
              Self URI (application/pdf): https://www.karger.com/Article/Pdf/73441
              Categories
              Original Paper

              Comments

              Comment on this article